No content results match your keyword.
Content
You have successfully logged out.
Not registered yet?
Tuesday, 10 February 2026
Cikampek, January 2026 – PT B. Braun Pharmaceutical Indonesia (PTBP) has achieved another important milestone in its commitment to ensuring a reliable and compliant medical device distribution system. On 12 January 2026, the company underwent the Good Distribution Practice for Medical Devices (CDAKB) Certification Audit conducted by the Ministry of Health of the Republic of Indonesia and successfully obtained an outstanding result: zero finding.
The audit covered the Medical Device warehouse of PTBP and the Technical Service Facility (TSF). The assessment was led by three auditors from the Ministry of Health: Rizky Firstya Novani, Maulana Muchammad, and Muhammad Istiqlal Yunus. Their evaluation focused on compliance with the CDAKB guidelines outlined in Ministry of Health Regulation No. 4 of 2014, which consists of thirteen key clauses, including quality management, facility standards, documentation control, and distribution monitoring.
The audit process was carried out thoroughly and systematically. The auditors reviewed physical facilities, examined documentation, and verified the readiness of supporting infrastructure to ensure full adherence to national distribution standards. Several departments participated as auditees during the assessment, including Warehouse-Logistic, Management Representative, Quality Management, HR, Production MD, EHSS, Purchasing, Engineering Maintenance, Campus Building, Marketing, and Technical Service.
The zero-finding result reflects the strong, well-structured, and compliant distribution system implemented by PT B. Braun Pharmaceutical Indonesia. Following this achievement, the company now awaits the issuance of the CDAKB certificate, which is expected to take approximately ten days.
This accomplishment underscores the company’s ongoing commitment to quality, regulatory compliance, and safety in every stage of medical device distribution. It also reinforces B. Braun’s position as a trusted provider of healthcare solutions that prioritize patient safety and dependable service delivery for healthcare facilities across Indonesia.
PT B. Braun Pharmaceutical Indonesia extends its appreciation to all teams involved. The company recognizes the importance of cross-functional collaboration, which played a crucial role in achieving an audit outcome with zero findings—an achievement that demonstrates the dedication and consistency of the entire organization.
